Gregory T. Carter

Gregory T. Carter

Auto-generated profile, based on publicly available information

Gregory T. Carter

St Luke's Rehabilitation Institute, 711 South Cowley Avenue, Spokane, WA 99202, USA

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2009 in Journal of Opioid Management
Verified
Journal Article
Open access
PDF file
SASunil K. Aggarwal
Sunil K. Aggarwal
GCGregory T. Carter
Gregory T. Carter
MSMark D. Sullivan
Mark D. Sullivan
CZCraig ZumBrunnen
Craig ZumBrunnen
RMRichard Morrill
Richard Morrill
JMJonathan D. Mayer
Jonathan D. Mayer
Cannabis (marijuana) has been used for medicinal purposes for millennia, said to be first noted by the Chinese in c. 2737 BCE. Medicinal cannabis arrived in the United States much later, burdened with a remarkably checkered, yet colorful, history. Despite early robust use, after the advent of opioids and aspirin, medicinal cannabis use faded. Cannabis was criminalized in the United States in 1937, against the advice of the American Medical Association submitted on record to Congress. The past few decades have seen renewed interest in medicinal cannabis, with the National Institutes of Health, the Institute of Medicine, and the American College of Physicians, all issuing statements of support for further research and development. The recently discovered endocannabinoid system has greatly increased our understanding of the actions of exogenous cannabis. Endocannabinoids appear to control pain, muscle tone, mood state, appetite, and inflammation, among other effects. Cannabis contains more than 100 different cannabinoids and has the capacity for analgesia through neuromodulation in ascending and descending pain pathways, neuroprotection, and anti-inflammatory mechanisms. This article reviews the current and emerging research on the physiological mechanisms of cannabinoids and their applications in managing chronic pain, muscle spasticity, cachexia, and other debilitating problems.

24 September 2008 in Muscle & Nerve
Verified
Journal Article
Closed access
PDF file
JWJohn H.J. Wokke
John H.J. Wokke
DEDiana M. Escolar
Diana M. Escolar
APAlan Pestronk
Alan Pestronk
KJKenneth M. Jaffe
Kenneth M. Jaffe
GCGregory T. Carter
Gregory T. Carter
PLPascal Laforet
Pascal Laforet

1 May 2014 in Physical Medicine and Rehabilitation Clinics of North America
Verified
Journal Article
Closed access
GCGregory T. Carter
Gregory T. Carter
VDVicky Duong
Vicky Duong
SHStanley Ho
Stanley Ho
KNKathryn C. Ngo
Kathryn C. Ngo
CGChristopher L. Greer
Christopher L. Greer
DWDouglas L. Weeks
Douglas L. Weeks

1 January 2002 in American Journal of Hospice and Palliative Medicine®
Verified
Journal Article
Closed access
PDF file
RARichard T. Abresch
Richard T. Abresch
GCGregory T. Carter
Gregory T. Carter
MJMark P. Jensen
Mark P. Jensen
DKDavid D. Kilmer
David D. Kilmer
Few studies have examined the effect of pain on the quality of life of individuals with slowly progressive neuromuscular disease (NMD). The purpose of this study was to determine the frequency and extent to which subjects with slowly progressive NMD report pain and the association between pain and health-related quality of life in persons with NMD. The study design was a descriptive, nonexperimental survey. Of a total of 1,432 subjects with slowly progressive NMDs recruited from a university-based NMD clinic and the membership rosters of worldwide NMD support organizations, 859 agreed to participate. The primary measurement tool used was the Medical Outcomes Study SF-36 health survey. Our results indicated that, with the exception of adult spinal muscular atrophy (SMA), the frequency and severity of pain reported in slowly progressive NMDs was significantly greater than levels of pain reported by the general US population and was comparable to pain reported by subjects with osteoarthritis and chronic low back pain. There was a significant correlation between increased pain and lower levels of general health, vitality, social function, and physical role. Pain was moderately associated with increased fatigue, inability to cope adequately with stress, and sleep disturbance. In conclusion, with the exception of adult SMA, the frequency and severity of pain reported in slowly progressive NMDs was significant.

1 June 2005 in Archives of Physical Medicine and Rehabilitation
Verified
Journal Article
Closed access
MJMark P. Jensen
Mark P. Jensen
RARichard T. Abresch
Richard T. Abresch
GCGregory T. Carter
Gregory T. Carter
CMCraig M. McDonald
Craig M. McDonald

1 January 2005 in Archives of Physical Medicine and Rehabilitation
Verified
Journal Article
Closed access
JEJohn D. England
John D. England
GGGary S. Gronseth
Gary S. Gronseth
GFGary Franklin
Gary Franklin
RMRobert G. Miller
Robert G. Miller
AAArthur K. Asbury
Arthur K. Asbury
ASAustin J. Sumner
Austin J. Sumner